logo
logo

Genapsys Announces $70 Million In Series D Equity Financing And Expansion Of Its Board Of Directors

May 27, 2021•about 4 years ago

Amount Raised

$70 Million

Round Type

series d

Redwood

Description

GenapSys, Inc. (GenapSys), a company developing a highly accurate and scalable electronic sequencing platform, today announced it has raised $70 million in a Series D equity financing. Investors in the round included Farallon Capital Management, L.L.C., Soleus Capital, an affiliate of PBM Capital, and additional new investors. Proceeds from this financing will be used to continue advancing GenapSys' semiconductor based next-generation sequencing (NGS) platform.

Company Information

Company

Genap Sys

Location

Redwood, Minnesota, United States

About

GenapSys is a company focused on the advancement of universal access to genomic information by delivering an affordable, scalable, and accurate genomic sequencing ecosystem that empowers both academic and clinical research applications. Its system leverages a proprietary electrical microfluidic sequencing chip with a scalable number of detectors, allowing for a wide range of applications. GenapSys is headquartered in Redwood City, CA. GenapSys products are provided for Research Use Only. Not for use in diagnostic procedures.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech